سعر بانتوبي 40 مجم 14 قرص 2024

Pantopi 40 mg pantoprazole tablets, pack of 14 (2 strips), by El-Obour (Egypt); proton pump inhibitor for peptic ulcer and reflux disease.

• Short-term treatment of erosive esophagitis associated with GERD (adults and children 5 years and older)Population: Adults and pediatric patients >=5 yearsDailyMed (U.S. National Library of Medicine)
• Maintenance of healing of erosive esophagitis (adults)Population: AdultsDailyMed (U.S. National Library of Medicine)
• Pathological hypersecretory conditions including Zollinger-Ellison syndrome (adults)Population: AdultsDailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to any component of the formulation or to any substituted benzimidazole (reactions may include anaphylaxis, angioedema, bronchospasm, acute tubulointerstitial nephritis, urticaria).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant use with rilpivirine-containing products.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Symptomatic response does not exclude gastric malignancy; consider further evaluation if response is suboptimal or symptoms relapse early.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Acute tubulointerstitial nephritis may occur at any time during PPI therapy; discontinue if suspected.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Possible increased risk of Clostridioides difficile-associated diarrhea, especially in hospitalised patients; use the lowest dose and shortest duration appropriate.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• RilpivirineContraindicated: reduced rilpivirine exposure and possible loss of virologic response.DailyMed (U.S. National Library of Medicine)
• WarfarinIncreased INR and prothrombin time reported; monitor INR.DailyMed (U.S. National Library of Medicine)
• Methotrexate (high dose)Concomitant use may raise and prolong methotrexate levels; consider temporary PPI withdrawal.DailyMed (U.S. National Library of Medicine)

• US label: available observational data have not shown an association with major malformations or other adverse pregnancy outcomes; animal reproduction studies were reassuring at relevant exposures.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• US label: pantoprazole is present in human milk (limited data); no effects on the breastfed infant have been reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Pantoprazole: Binds covalently to the parietal-cell H+/K+-ATPase (proton pump), suppressing the final step of gastric acid production (US label 12.1).